Company Overview of Sirius Genomics Inc.
Sirius Genomics Inc. develops DNA-based companion diagnostics and pharmacogenetic tests for people with acute medical conditions. The company focuses on severe sepsis, a condition which impacts patients in the United States. It offers activated protein C companion diagnostics, a molecular diagnostic test to identify patients who will respond to activated protein C, a drug for sepsis. Sirius Genomics Inc. was founded in 2001 and is based in Vancouver, Canada.
1125 Howe Street
Vancouver, BC V6Z 2K8
Founded in 2001
Key Executives for Sirius Genomics Inc.
Similar Private Companies By Industry
|Glyko Biomedical Ltd.||Americas|
|Thallion Pharmaceuticals, Inc.||Americas|
|DalCor Pharmaceuticals Canada Inc.||Americas|
|Tissue Regeneration Therapeutics Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Sirius Genomics Inc., please visit www.siriusgenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.